Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Apr;23(4):631-8.
doi: 10.1007/s00467-007-0716-7. Epub 2008 Jan 23.

Evaluating methods for improving ultrafiltration in pediatric hemodialysis

Affiliations

Evaluating methods for improving ultrafiltration in pediatric hemodialysis

Daljit K Hothi et al. Pediatr Nephrol. 2008 Apr.

Abstract

Adequate ultrafiltration (UF) is necessary for good health, but it can be hindered by the development of intradialytic symptoms and hypotension. To determine whether sodium ramping, UF profiles and mannitol could improve UF in children, we instituted a standardized prescription for chronic hemodialysis in our unit. We prospectively analyzed 506 treatments from ten patients. Ultrafiltration volumes up to 9.7% of dry weight were obtained with an overall mean of 5.4%. Mannitol reduced the risk of intradialytic symptoms by 64% (p < 0.05) with a mean UF volume of 6.2%. Step sodium ramping from 148-138 mmol/l reduced the odds of intradialytic symptoms (p = 0.1) and hypotension (p < 0.05) with no difference in the mean UF compared with linear profiles. All UF profiles were associated with an increased risk of intradialytic symptoms, but the effect was only statistically significant with profile 2 (stepwise UF reduction). Overall intradialytic morbidity occurred in 10% of the treatments. Notwithstanding the study limitations, UF volumes higher than traditional recommendations of 5% of the dry weight were achieved with the use of mannitol and 148-138 mmol/l sodium ramping. Despite this, the desired dry weight was not achieved in 66% of our treatments. No clear benefit was seen with UF profiles.

PubMed Disclaimer

Similar articles

Cited by

References

    1. BMJ. 1994 May 21;308(6940):1349-55 - PubMed
    1. Am J Kidney Dis. 2002 Sep;40(3):556-65 - PubMed
    1. Pediatr Nephrol. 2001 Jan;16(1):15-8 - PubMed
    1. Nephron. 1997;75(3):264-71 - PubMed
    1. Pediatr Nephrol. 2005 Aug;20(8):1054-66 - PubMed

LinkOut - more resources